KemPharm

$1.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.89 (+433.98%) Today
+$0.04 (+3.64%) As of 1:10 PM EST after-hours

Why Robinhood?

You can watch KemPharm and buy or sell other stocks, options, and ETFs commission-free!

About KMPH

KemPharm, Inc. Common Stock, also called KemPharm, is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA. The listed name for KMPH is KemPharm, Inc. Common Stock.

CEO
Travis C. Mickle
Employees
22
Headquarters
Celebration, Florida
Founded
2006
Market Cap
79.80M
Price-Earnings Ratio
Dividend Yield
Average Volume
868.19K
High Today
$1.30
Low Today
$1.09
Open Price
$1.30
Volume
586.81K
52 Week High
$1.38
52 Week Low
$0.121

Collections

You May Also Like